Kalaris Therapeutics, Inc. (KLRS) has 4 open-market insider trades by 3 insiders since 2025. Over the last six months insiders net bought $1.2M. The most active filer is Brett R. Hagen, CAO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Opportunity Fund L.p. Samsara | 10% | — | 1 | $5.0M | 2025-12-18 |
| Srinivas Akkaraju | Dir10% Owner | — | 1 | $1.2M | 2026-05-20 |
| Brett R. Hagen | CAO | — | 2 | $21K | 2026-03-20 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Srinivas Akkaraju | Director & 10% Owner | Buy | $1.2M | 2026-05-20 |
| Brett R. Hagen | CAO | Sell | $13K | 2026-03-20 |
| Opportunity Fund L.p. Samsara | 10% | Buy | $5.0M | 2025-12-18 |
| Brett R. Hagen | Chief Accounting Officer | Sell | $8K | 2025-03-26 |
Companies that share insiders with KLRS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.